Jiangsu Hengrui Medicine
600276.SS
#479
Rank
ยฃ33.70 B
Marketcap
ยฃ5.28
Share price
-1.82%
Change (1 day)
-1.54%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Market capitalization of Jiangsu Hengrui Medicine (600276.SS)

Market cap: ยฃ33.70 Billion

As of November 2024 Jiangsu Hengrui Medicine has a market cap of ยฃ33.70 Billion. This makes Jiangsu Hengrui Medicine the world's 479th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jiangsu Hengrui Medicine from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ33.70 B5.62%
2023ยฃ31.90 B9.54%
2022ยฃ29.12 B-22.75%
2021ยฃ37.70 B-43.59%
2020ยฃ66.84 B58.19%
2019ยฃ42.25 B89.92%
2018ยฃ22.24 B1.08%
2017ยฃ22.01 B76.61%
2016ยฃ12.46 B24.56%
2015ยฃ10.00 B71.12%
2014ยฃ5.84 B12.99%
2013ยฃ5.17 B40.11%
2012ยฃ3.69 B9.44%
2011ยฃ3.37 B-22.82%
2010ยฃ4.37 B48.31%
2009ยฃ2.94 B47.79%
2008ยฃ1.99 B18.33%
2007ยฃ1.68 B140.7%
2006ยฃ0.70 B159.01%
2005ยฃ0.27 B34.92%
2004ยฃ0.20 B38.5%
2003ยฃ0.14 B-25%
2002ยฃ0.19 B-35.73%
2001ยฃ0.30 B-7.4%
2000ยฃ0.32 B